About
Real-time cancer cell visualization for surgical applications
Areas of Focus
Categories
Non-PharmaceuticalSeattle/Pacific Northwest
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
259
By Phase
PHASE1/PHASE2: 1PHASE2: 1PHASE2/PHASE3: 1PHASE1: 4
By Status
COMPLETED: 5RECRUITING: 1WITHDRAWN: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05316688Collaborator
A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery
PHASE1/PHASE2Recruiting
15 participants
Started: Apr 17, 2024 · Completed: Jan 20, 2027
NCT04743310Collaborator
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
PHASE2Completed
50 participants
Started: Sep 30, 2021 · Completed: Mar 6, 2025
NCT03579602Lead Sponsor
Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery
PHASE2/PHASE3Completed
118 participants
Started: Nov 26, 2018 · Completed: Jun 13, 2022
NCT02464332Lead Sponsor
Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery
PHASE1Withdrawn
Started: Sep 30, 2015 · Completed: May 31, 2016
NCT02496065Lead Sponsor
Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery
PHASE1Completed
30 participants
Started: Jul 31, 2015 · Completed: Jan 31, 2017
Locations (1)
Headquarters
Seattle, WA, United States
Map
Loading map...